Crinetics Pharmaceuticals, Inc. (CRNX)

39.76 -0.36 (-0.90%) USD  |  NASDAQ  |  Mar 04, 10:48
More

Crinetics Pharmaceuticals Stock Based Compensation (Annual Per Share)

Stock Based Compensation (Annual Per Share) Chart

View Stock Based Compensation (Annual Per Share) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual Per Share) Range, Past 5 Years

View Stock Based Compensation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual Per Share) Benchmarks

View Stock Based Compensation (Annual Per Share) Benchmarks
Start Trial
Plus Therapeutics, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade